Literature DB >> 34368852

Aperture: alignment-free detection of structural variations and viral integrations in circulating tumor DNA.

Hongchao Liu1, Huihui Yin2, Guangyu Li1, Junling Li3, Xiaoyue Wang1.   

Abstract

The identification of structural variations (SVs) and viral integrations in circulating tumor DNA (ctDNA) is a key step in precision oncology that may assist clinicians in treatment selection and monitoring. However, due to the short fragment size of ctDNA, it is challenging to accurately detect low-frequency SVs or SVs involving complex junctions in ctDNA sequencing data. Here, we describe Aperture, a new fast SV caller that applies a unique strategy of $k$-mer-based searching, binary label-based breakpoint detection and candidate clustering to detect SVs and viral integrations with high sensitivity, especially when junctions span repetitive regions. Aperture also employs a barcode-based filter to ensure specificity. Compared with existing methods, Aperture exhibits superior sensitivity and specificity in simulated, reference and real data tests, especially at low dilutions. Additionally, Aperture is able to predict sites of viral integration and identify complex SVs involving novel insertions and repetitive sequences in real patient data. Aperture is freely available at https://github.com/liuhc8/Aperture.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  cfDNA; ctDNA; structural variation; viral integration

Mesh:

Substances:

Year:  2021        PMID: 34368852     DOI: 10.1093/bib/bbab290

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   11.622


  1 in total

1.  A protocol to clinically evaluate liquid biopsies as a tool to speed up diagnosis of children and young adults with aggressive infection-related lymphoma in East Africa "(AI-REAL)".

Authors:  Ismail D Legason; Martin D Ogwang; Clara Chamba; Elifuraha Mkwizu; Claire El Mouden; Hadija Mwinula; Lulu Chirande; Anna Schuh; Faraja Chiwanga
Journal:  BMC Cancer       Date:  2022-05-02       Impact factor: 4.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.